StockNews.com Initiates Coverage on SenesTech (NASDAQ:SNES)

Research analysts at StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES) in a research report issued on Monday. The brokerage set a “sell” rating on the stock.

Separately, HC Wainwright lifted their price objective on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.

SenesTech Trading Down 1.3 %

NASDAQ SNES opened at $2.21 on Monday. SenesTech has a twelve month low of $1.90 and a twelve month high of $9.80. The company has a debt-to-equity ratio of 0.05, a quick ratio of 4.92 and a current ratio of 6.32. The stock has a market cap of $2.29 million, a price-to-earnings ratio of -0.22 and a beta of 0.09. The firm’s 50 day moving average price is $2.97 and its two-hundred day moving average price is $2.83.

SenesTech (NASDAQ:SNES) last posted its quarterly earnings data on Wednesday, March 12th. The company reported ($1.22) earnings per share for the quarter, topping the consensus estimate of ($1.50) by $0.28. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. The firm had revenue of $0.50 million for the quarter, compared to analysts’ expectations of $0.71 million. Equities analysts anticipate that SenesTech will post -10.22 EPS for the current year.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.